BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35431360)

  • 21. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
    Sabirova Z; Mahnoor S; Lasfar D; Gagné V; Théorêt Y; Leclerc JM; Laverdière C; Sinnett D; Tran TH; Krajinovic M
    Pharmacogenet Genomics; 2024 Jul; 34(5):170-173. PubMed ID: 38682355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
    Moriyama T; Nishii R; Perez-Andreu V; Yang W; Klussmann FA; Zhao X; Lin TN; Hoshitsuki K; Nersting J; Kihira K; Hofmann U; Komada Y; Kato M; McCorkle R; Li L; Koh K; Najera CR; Kham SK; Isobe T; Chen Z; Chiew EK; Bhojwani D; Jeffries C; Lu Y; Schwab M; Inaba H; Pui CH; Relling MV; Manabe A; Hori H; Schmiegelow K; Yeoh AE; Evans WE; Yang JJ
    Nat Genet; 2016 Apr; 48(4):367-73. PubMed ID: 26878724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
    Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Raghav L; Chang HH; Wu KH; Chou SW; Ni YL; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2020 Sep; 10(1):14400. PubMed ID: 32873882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
    Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
    Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine.
    Khaeso K; Komvilaisak P; Chainansamit SO; Nakkam N; Suwannaying K; Kuwatjanakul P; Hikino K; Dornsena A; Kanjanawart S; Laoaroon N; Vannaprasaht S; Taketani T; Tassaneeyakul W
    Drug Metab Pharmacokinet; 2022 Apr; 43():100436. PubMed ID: 35016134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic determinants of thiopurines in an Indian cohort.
    Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
    Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment.
    Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of TPMT and ITPA variants in mercaptopurine disposition.
    Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay.
    Soler AM; Olano N; Méndez Y; Lopes A; Silveira A; Dabezies A; Castillo L; da Luz JA
    Br J Haematol; 2018 Apr; 181(2):252-255. PubMed ID: 28146264
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].
    He J; Liu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):100-104. PubMed ID: 30675872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.
    Stocco G; Crews KR; Evans WE
    Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population.
    Ramalingam R; Kaur H; Scott JX; Sneha LM; Arun Kumar GP; Srinivasan A; Paul SF
    Pharmacogenomics; 2021 May; 22(7):401-411. PubMed ID: 33876659
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of
    Nguyen ML; Hoang AV; Duong BT; Phung NTN
    HGG Adv; 2023 Apr; 4(2):100183. PubMed ID: 36873097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia.
    Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Cheng CN; Chang HH; Chou SW; Su MY; Ni YL; Xu PY; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2023 Jan; 13(1):490. PubMed ID: 36627439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.
    Dorababu P; Nagesh N; Linga VG; Gundeti S; Kutala VK; Reddanna P; Digumarti R
    Eur J Clin Pharmacol; 2012 Apr; 68(4):379-87. PubMed ID: 22009189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
    Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
    Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel variants in
    Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
    Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of common and novel rare
    Zhu Y; Yin D; Su Y; Xia X; Moriyama T; Nishii R; Liao F; Zhang S; Guo X; Hou Q; Ai Y; Zhou X; Sun S; Zhang D; Zhang Y; Lin C; Deng Y; Lu X; Wang Y; Ma Z; Wang H; Liu B; Yang L; Zhang W; Yang JJ; Shu Y; Gao J; Xu H
    Haematologica; 2018 Jul; 103(7):e293-e295. PubMed ID: 29519865
    [No Abstract]   [Full Text] [Related]  

  • 39. Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT.
    Park Y; Kim H; Seo H; Choi JY; Ma Y; Yun S; Min BJ; Seo ME; Yoo KH; Kang HJ; Im HJ; Kim JH
    J Transl Med; 2020 Jul; 18(1):265. PubMed ID: 32611418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.